Business - Briefly   

Dr. Reddy's launches `Viboliv'

HYDERABAD: Dr. Reddy's Laboratories has announced the nationwide launch of `Viboliv' (Metadoxine) in 500 mg tablet and 300 mg injectable form. Metadoxine has a direct effect on alcohol metabolism, accelerates the transformation of alcohol into acetaldehyde and there on its urinary excretion. Viboliv is licensed from Eurodrug Laboratories, Belgium, and is the third licensed product to be introduced by Dr. Reddy's during the calendar year.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

G-20 favours reform of IMF, World Bank
India alleges foul play in PetroKazakhstan bid
SPEL Semiconductor draws up road-map for designing
Export growth dips in Sept.
Stocks end flat in volatile trading
Rupee turns weak after a firm start
Imation's Indian subsidiary
Allahabad Bank plans overseas branch
NADI group expands capacity of JVs
Air Deccan launches shopping scheme
Exchange rates
Bullion rates
TRAI concerned over rising congestion
Cisco President to visit India
Dr. Reddy's launches `Viboliv'
TNPL net doubles in Q2
Bosch, Brembo form 50:50 joint venture
OP Steels merger with Kanishk Steel
ICBC sets up container freight station
Temasek Holdings invests in Medreich Group
Bharat Gears pact with Ramco Systems
Bell Granito Ceramica opens Chennai office
IDEA's new mobile switching centre
Vimta Labs posts Rs. 13.69 cr. revenue in Q2
EPCglobal India Conference-cum-Exhibition
Eureka Forbes wins award
IndusInd Bank offers new product
7th BFSI Tech India 2005
Nokia appoints distributor in India
Pantaloon Retail opens fashion store
Brooke Bond's `spread a smile coupon' offer
Dabur to consider bonus issue
Escorts appoints whole time director

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu